Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

A leading prostate cancer surgeon has marked the incredible milestone of performing 3,000 robotic radical prostatectomy ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

With the advent of robotic surgery and its use during radical prostatectomy, surgeons have been able to better identify those tissue planes secondary to the improved magnified 10 × 3D vision.

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

A new study published in the Nature Scientific Reports highlighted the potential benefits of aspirin in reducing biochemical ...